Kopran Limited (BOM:524280)

Market Cap	6.32B
Revenue (ttm)	6.19B
Net Income (ttm)	165.43M
Shares Out	48.29M
EPS (ttm)	3.42
PE Ratio	38.31
Forward PE	n/a
Dividend	3.00 (2.21%)
Ex-Dividend Date	Sep 4, 2025

Volume	4,667
Average Volume	18,174
Open	144.00
Previous Close	145.05
Day's Range	142.05 - 144.00
52-Week Range	123.75 - 216.25
Beta	0.40
RSI	33.33
Earnings Date	Jan 22, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In 2024, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.